Aurinia Pharmaceuticals Inc.
AUPH
Revenue
57.19M
▲6.89M▲13.70%
3 Months ChangeAssets
326.68M
▲180.82M▲123.97%
12 Months ChangeLiabilities
53.17M
▲19.88M▲59.72%
12 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-12
Form 8-K
ID: 0001600620-24-000099
2024-08-01
Form 10-Q
ID: 0001600620-24-000091
2024-08-01
Form 8-K
ID: 0001600620-24-000089
2024-06-14
Form 8-K
ID: 0001600620-24-000087
2024-05-02
Form 10-Q
ID: 0001600620-24-000051
2024-05-02
Form 8-K
ID: 0001600620-24-000049
2024-02-29
Form 8-K
ID: 0001600620-24-000027
2024-02-15
Form 8-K
ID: 0001600620-24-000010
2024-01-05
Form 8-K
ID: 0001600620-24-000001
2023-11-02
Form 10-Q
ID: 0001600620-23-000044